News Nunzia Pharmaceutical Company

Equities

NUNZ

US67097W1027

Delayed OTC Markets Other stock markets 08:10:00 2023-12-01 pm EST			5-day change	1st Jan Change
0.003 ^USD	-.--%		-.--%	-.--%

2022	Nunzia Pharmaceutical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
2022	Nunzia Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-14	AQ
Nunzia Pharmaceutical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-10-03	AQ
Nunzia Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-10-03	CI
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-05-23	AQ
Nunzia Pharmaceutical Company Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
NUNZIA PHARMACEUTICAL CO MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22-04-15	AQ
Nunzia Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-15	CI
Nunzia Pharmaceutical Company Auditor Raises 'Going Concern' Doubt	22-04-14	CI
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q/A)	22-03-29	AQ
Nunzia Pharmaceutical Company Auditor Raises 'Going Concern' Doubt	22-03-28	CI
Nunzia Pharmaceutical : Annual Report Late filing	22-03-28	PU
NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)	22-03-18	AQ
NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)	22-03-02	AQ
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21-11-10	AQ
Nunzia Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
NUNZIA PHARMACEUTICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	21-09-16	AQ
Nunzia Pharmaceutical Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020	21-09-16	CI
NUNZIA PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21-09-16	AQ
NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)	21-08-17	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Nunzia Pharmaceutical Company

Equities

NUNZ

US67097W1027

Summary

Filters